Antimalarial pantothenamide metabolites target acetyl–coenzyme A biosynthesis in Plasmodium falciparum
暂无分享,去创建一个
M. Llinás | P. Jansen | K. Dechering | R. Sauerwein | J. Schalkwijk | F. Rutjes | S. Jackowski | J. Bolscher | Erik L. Allman | T. W. Kooij | G. Trevitt | M. Jiménez-Díaz | Iñigo Angulo-Barturen | S. Wittlin | P. Hermkens | Karin M. J. Koolen | Martijn W. Vos | R. Blaauw | K. M. Koolen | G. Josling | P. Botman | C. Scheurer | Laura E. de Vries | Christien A. Beuckens-Schortinghuis | K. Miller | Stacy A. Reeves | H. Pett | Sibylle Sax | Christoph Fischli | R. Bonnert | B. Campo | Julie M. J. Verhoef | Helmi E Pett | T. Kooij
[1] A. Aly,et al. The antimalarial activity of the pantothenamide α-PanAm is via inhibition of pantothenate phosphorylation , 2017, Scientific Reports.
[2] C. Spry,et al. Mutations in the pantothenate kinase of Plasmodium falciparum confer diverse sensitivity profiles to antiplasmodial pantothenate analogues , 2017, bioRxiv.
[3] A. Aly,et al. Genetic Characterization of Coenzyme A Biosynthesis Reveals Essential Distinctive Functions during Malaria Parasite Development in Blood and Mosquito , 2017, Front. Cell. Infect. Microbiol..
[4] C. Spry,et al. Antiplasmodial Mode of Action of Pantothenamides: Pantothenate Kinase Serves as a Metabolic Activator Not as a Target. , 2017, ACS infectious diseases.
[5] J. Burrows,et al. New developments in anti-malarial target candidate and product profiles , 2017, Malaria Journal.
[6] K. Saliba,et al. Biological characterization of chemically diverse compounds targeting the Plasmodium falciparum coenzyme A synthesis pathway , 2016, Parasites & Vectors.
[7] Victoria C. Corey,et al. UDP-galactose and Acetyl-CoA transporters as Plasmodium multidrug resistance genes , 2016, Nature Microbiology.
[8] K. Saliba,et al. Triazole Substitution of a Labile Amide Bond Stabilizes Pantothenamides and Improves Their Antiplasmodial Potency , 2016, Antimicrobial Agents and Chemotherapy.
[9] Manuel Llinás,et al. Metabolomic Profiling of the Malaria Box Reveals Antimalarial Target Pathways , 2016, Antimicrobial Agents and Chemotherapy.
[10] K. Dechering,et al. Analysis of the dose-dependent stage-specific in vitro efficacy of a multi-stage malaria vaccine candidate cocktail , 2016, Malaria Journal.
[11] K. Saliba,et al. A cross-metathesis approach to novel pantothenamide derivatives , 2016, Beilstein journal of organic chemistry.
[12] K. Matuschewski,et al. Functional profiles of orphan membrane transporters in the life cycle of the malaria parasite , 2016, Nature Communications.
[13] Teun Bousema,et al. A semi-automated luminescence based standard membrane feeding assay identifies novel small molecules that inhibit transmission of malaria parasites by mosquitoes , 2015, Scientific Reports.
[14] Ruth Ayanful-Torgby,et al. An improved SYBR Green-1-based fluorescence method for the routine monitoring of Plasmodium falciparum resistance to anti-malarial drugs , 2015, Malaria Journal.
[15] M. Llinás,et al. Mutations in the Plasmodium falciparum chloroquine resistance transporter, PfCRT, enlarge the parasite’s food vacuole and alter drug sensitivities , 2015, Scientific Reports.
[16] Farah El Mazouni,et al. A long-duration dihydroorotate dehydrogenase inhibitor (DSM265) for prevention and treatment of malaria , 2015, Science Translational Medicine.
[17] T. Bousema,et al. A combination of new screening assays for prioritization of transmission-blocking antimalarials reveals distinct dynamics of marketed and experimental drugs. , 2015, The Journal of antimicrobial chemotherapy.
[18] P. Jansen,et al. Novel pantothenate derivatives for anti-malarial chemotherapy , 2015, Malaria Journal.
[19] K. Saliba,et al. A Pantetheinase-Resistant Pantothenamide with Potent, On-Target, and Selective Antiplasmodial Activity , 2015, Antimicrobial Agents and Chemotherapy.
[20] K. Saliba,et al. Stereochemical modification of geminal dialkyl substituents on pantothenamides alters antimicrobial activity. , 2014, Bioorganic & medicinal chemistry letters.
[21] A. Aly,et al. Plasmodium yoelii Vitamin B5 Pantothenate Transporter Candidate is Essential for Parasite Transmission to the Mosquito , 2014, Scientific Reports.
[22] C. MacPherson,et al. Genome editing in the human malaria parasite Plasmodium falciparum using the CRISPR-Cas9 system , 2014, Nature Biotechnology.
[23] Manuel Llinás,et al. Kinetic Flux Profiling Elucidates Two Independent Acetyl-CoA Biosynthetic Pathways in Plasmodium falciparum* , 2013, The Journal of Biological Chemistry.
[24] P. Jansen,et al. Combination of pantothenamides with vanin inhibitors as a novel antibiotic strategy against gram-positive bacteria. , 2013, Antimicrobial agents and chemotherapy.
[25] N. White. Pharmacokinetic and Pharmacodynamic Considerations in Antimalarial Dose Optimization , 2013, Antimicrobial Agents and Chemotherapy.
[26] C. Spry,et al. Structural modification of pantothenamides counteracts degradation by pantetheinase and improves antiplasmodial activity. , 2013, ACS medicinal chemistry letters.
[27] C. Spry,et al. Pantothenamides Are Potent, On-Target Inhibitors of Plasmodium falciparum Growth When Serum Pantetheinase Is Inactivated , 2013, PloS one.
[28] Geoffrey L. Johnston,et al. Mitotic Evolution of Plasmodium falciparum Shows a Stable Core Genome but Recombination in Antigen Families , 2013, PLoS genetics.
[29] X. Su,et al. Malaria biology and disease pathogenesis: insights for new treatments , 2013, Nature Medicine.
[30] P. Jansen,et al. Discovery of small molecule vanin inhibitors: new tools to study metabolism and disease. , 2013, ACS chemical biology.
[31] Daniel Amador-Noguez,et al. Metabolomic analysis via reversed-phase ion-pairing liquid chromatography coupled to a stand alone orbitrap mass spectrometer. , 2010, Analytical chemistry.
[32] L. Shultz,et al. Improved Murine Model of Malaria Using Plasmodium falciparum Competent Strains and Non-Myelodepleted NOD-scid IL2Rγnull Mice Engrafted with Human Erythrocytes , 2009, Antimicrobial Agents and Chemotherapy.
[33] C. Spry,et al. The Human Malaria Parasite Plasmodium falciparum Is Not Dependent on Host Coenzyme A Biosynthesis* , 2009, The Journal of Biological Chemistry.
[34] C. Rock,et al. Localization and regulation of mouse pantothenate kinase 2 , 2007, FEBS letters.
[35] C. Rock,et al. Crystal Structures of Human Pantothenate Kinases , 2007, Journal of Biological Chemistry.
[36] C. Spry,et al. Feedback Inhibition of Pantothenate Kinase Regulates Pantothenol Uptake by the Malaria Parasite* , 2007, Journal of Biological Chemistry.
[37] J. Chollet,et al. In vitro and in vivo interaction of synthetic peroxide RBx11160 (OZ277) with piperaquine in Plasmodium models. , 2007, Experimental parasitology.
[38] Elena R. Lozovsky,et al. Duplication, gene conversion, and genetic diversity in the species-specific acyl-CoA synthetase gene family of Plasmodium falciparum. , 2006, Molecular and biochemical parasitology.
[39] C. Rock,et al. A Pantothenate Kinase from Staphylococcus aureus Refractory to Feedback Regulation by Coenzyme A* , 2005, Journal of Biological Chemistry.
[40] K. Kirk,et al. Provitamin B5 (Pantothenol) Inhibits Growth of the Intraerythrocytic Malaria Parasite , 2005, Antimicrobial Agents and Chemotherapy.
[41] C. Rock,et al. Acyl Carrier Protein Is a Cellular Target for the Antibacterial Action of the Pantothenamide Class of Pantothenate Antimetabolites* , 2004, Journal of Biological Chemistry.
[42] E. Strauss,et al. The Antibiotic Activity of N-Pentylpantothenamide Results from Its Conversion to Ethyldethia-Coenzyme A, a Coenzyme A Antimetabolite* , 2002, The Journal of Biological Chemistry.
[43] M. Gatton,et al. Mutations in Cytochrome b Resulting in Atovaquone Resistance Are Associated with Loss of Fitness in Plasmodium falciparum , 2002, Antimicrobial Agents and Chemotherapy.
[44] T. Wellems,et al. Transformation of malaria parasites by the spontaneous uptake and expression of DNA from human erythrocytes. , 2001, Nucleic acids research.
[45] K Polkowski,et al. Biological properties of genistein. A review of in vitro and in vivo data. , 2000, Acta poloniae pharmaceutica.
[46] K. Kirk,et al. Transport and Metabolism of the Essential Vitamin Pantothenic Acid in Human Erythrocytes Infected with the Malaria ParasitePlasmodium falciparum * , 1998, The Journal of Biological Chemistry.
[47] R. Farinotti,et al. Clinical Pharmacokinetics and Metabolism of Chloroquine , 1996, Clinical pharmacokinetics.
[48] G. Harding,et al. The Postantibiotic Effect: A Review of in Vitro and in Vivo Data , 1991, DICP : the annals of pharmacotherapy.
[49] J H Meuwissen,et al. Synchronization of Plasmodium falciparum gametocytes using an automated suspension culture system , 1986, Parasitology.
[50] J. Jensen,et al. Nutritional requirements of Plasmodium falciparum in culture. I. Exogenously supplied dialyzable components necessary for continuous growth. , 1985, The Journal of protozoology.
[51] C. Rock,et al. Regulation of coenzyme A biosynthesis , 1981, Journal of bacteriology.
[52] C. G. Skinner,et al. N'-(substituted) pantothenamides, antimetabolites of pantothenic acid. , 1970, Archives of biochemistry and biophysics.
[53] A. D’Alessandro,et al. The red blood cell proteome and interactome: an update. , 2010, Journal of proteome research.
[54] C. Spry,et al. Coenzyme A biosynthesis: an antimicrobial drug target. , 2008, FEMS microbiology reviews.
[55] Weltgesundheitsorganisation. World malaria report , 2005 .
[56] K. Johnson. An Update. , 1984, Journal of food protection.